Core Viewpoint - The establishment of the Anhui Gaotou Guotai Haitong Health M&A Equity Investment Fund Partnership (Limited Partnership) with a capital contribution of 500 million yuan indicates a strategic move towards private equity investment in the health sector [1] Group 1 - The newly formed fund will engage in activities such as private equity investment, investment management, and asset management [1] - The fund is co-funded by Junshi Biosciences and Guotai Haitong's wholly-owned subsidiary, Guotai Junan Innovation Investment Co., Ltd. [1]